PATRICIA BAXTER to Piperazines
This is a "connection" page, showing publications PATRICIA BAXTER has written about Piperazines.
Connection Strength
0.239
-
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042). Pediatr Blood Cancer. 2021 04; 68(4):e28879.
Score: 0.161
-
Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates. Cancer Chemother Pharmacol. 2011 Apr; 67(4):809-12.
Score: 0.078